C07F 9/62
Isoquinoline or hydrogenated isoquinoline ring systems
C07F9/62 (Isoquinoline or hydrogenated isoquinoline ring systems) appears on 88 US grants and 47 published applications in this corpus.
Search patents in C07F- Granted patents
- 88
- Published applications
- 47
- Assignees
- 44
- Inventors
- 208
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 9 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 3 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 2 | 3 |
| 2017 | 2 | 5 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 4 | 5 |
| 2021 | 2 | 0 |
| 2022 | 3 | 2 |
| 2023 | 2 | 4 |
| 2024 | 2 | 1 |
| 2025 | 1 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof25 Mar 2025US 12,258,317 B2Sunshine Lake Pharma Co., Ltd.
- Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders25 Jun 2024US 12,016,856 B2Ardelyx, Inc.
- Photo-cleavable primer compositions and methods of use7 May 2024US 11,976,219 B2Ormco Corporation
- Surface primer compositions and methods of use29 Aug 2023US 11,739,223 B2Envista
- Substituted bicyclic compounds18 Jul 2023US 11,701,373 B2Bristol-Myers Squibb Company
- Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof10 Sep 2026US 2026/0263431 A1Allianthera Boston Inc.
- Enhanced inhibitors of enpp1 and uses thereof10 Sep 2026US 2026/0263604 A1Petragen, Inc.
- Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease7 May 2026US 2026/0125346 A1BeOne Medicines I GmbH
- Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders4 Dec 2025US 2025/0367188 A1Ardelyx, Inc.
- Compounds and methods for yap/tead modulation and indications therefor24 Apr 2025US 2025/0129028 A1Opna Bio SA
Most cited
By later US patents
- HIV protease inhibitors80US 5,484,926 AAgouron Pharmaceuticals, Inc. · 1996
- Phosphonic acid derivatives65US 5,719,303 AEisai Co., Ltd. · 1998
- Excitatory amino acid receptor antagonists57US 4,902,695 AEli Lilly and Company · 1990
- Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives56US 4,452,790 AE. R. Squibb & Sons, Inc. · 1984
- Phosphorus containing compounds and use as hypotensives56US 4,555,506 AE. R. Squibb & Sons, Inc. · 1985